Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Walter

Showing results (191-200 of 334) with videos related to

Pageof 34
Sort By:
The American Journal of Pathology|January 13, 2011
Targeting the PI3K/mTOR pathway in murine endocrine cell lines: in vitro and in vivo effects on tumor cell growthChristophe Couderc, Gilles Poncet, Karine Villaume, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|February 2, 2018
Feasibility of a Single Contrast Bolus High-Pitch Pulmonary CT Angiography Protocol Followed by Low-Dose Retrospectively ECG-Gated Cardiac CT in Patients with Suspected Pulmonary EmbolismJulia Carmen Schäfer, Holger Haubenreisser, Mathias Meyer, et al.
Cell Reports. Medicine|December 14, 2022
Deep learning identifies morphological patterns of homologous recombination deficiency in luminal breast cancers from whole slide imagesTristan Lazard, Guillaume Bataillon, Peter Naylor, et al.
Oncotarget|April 21, 2017
mTOR inhibitors activate PERK signaling and favor viability of gastrointestinal neuroendocrine cell linesPatricia Freis, Julien Bollard, Justine Lebeau, et al.
Endocrine Oncology (Bristol, England)|July 12, 2023
cfDNA in pancreatic neuroendocrine carcinoma management with Cushing's syndromeLaura Gerard, David Barthelemy, Arnaud Gauthier, et al.
Journal of Molecular Biology|May 27, 2020
Phage G Structure at 6.1 Å Resolution, Condensed DNA, and Host Identity Revision to a LysinibacillusBrenda González, Lyman Monroe, Kunpeng Li, et al.
Clinics and Research in Hepatology and Gastroenterology|June 5, 2018
Immunosuppressive regimen and risk for de novo malignancies after liver transplantation for alcoholic liver diseaseJérôme Dumortier, Delphine Maucort-Boulch, Domitille Poinsot, et al.
Cancer|May 28, 2009
Gemcitabine and oxaliplatin combination chemotherapy for metastatic well-differentiated neuroendocrine carcinomas: a single-center experiencePhilippe A Cassier, Thomas Walter, Beatrice Eymard, et al.
In Vivo (Athens, Greece)|October 19, 2010
Thrombogenicity of sirolimus-eluting stents and bare metal stents: evaluation in the early phase after stent implantationThomas Walter, Katja S Rey, Hans Peter Wendel, et al.
Neuroendocrinology|May 10, 2019
Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine TumorLouis de Mestier, Thomas Walter, Camille Evrard, et al.
Pageof 34

Showing results (191-200 of 334) with videos related to

Sort By:
Pageof 34
The American Journal of Pathology|January 13, 2011
Targeting the PI3K/mTOR pathway in murine endocrine cell lines: in vitro and in vivo effects on tumor cell growthChristophe Couderc, Gilles Poncet, Karine Villaume, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|February 2, 2018
Feasibility of a Single Contrast Bolus High-Pitch Pulmonary CT Angiography Protocol Followed by Low-Dose Retrospectively ECG-Gated Cardiac CT in Patients with Suspected Pulmonary EmbolismJulia Carmen Schäfer, Holger Haubenreisser, Mathias Meyer, et al.
Cell Reports. Medicine|December 14, 2022
Deep learning identifies morphological patterns of homologous recombination deficiency in luminal breast cancers from whole slide imagesTristan Lazard, Guillaume Bataillon, Peter Naylor, et al.
Oncotarget|April 21, 2017
mTOR inhibitors activate PERK signaling and favor viability of gastrointestinal neuroendocrine cell linesPatricia Freis, Julien Bollard, Justine Lebeau, et al.
Endocrine Oncology (Bristol, England)|July 12, 2023
cfDNA in pancreatic neuroendocrine carcinoma management with Cushing's syndromeLaura Gerard, David Barthelemy, Arnaud Gauthier, et al.
Journal of Molecular Biology|May 27, 2020
Phage G Structure at 6.1 Å Resolution, Condensed DNA, and Host Identity Revision to a LysinibacillusBrenda González, Lyman Monroe, Kunpeng Li, et al.
Clinics and Research in Hepatology and Gastroenterology|June 5, 2018
Immunosuppressive regimen and risk for de novo malignancies after liver transplantation for alcoholic liver diseaseJérôme Dumortier, Delphine Maucort-Boulch, Domitille Poinsot, et al.
Cancer|May 28, 2009
Gemcitabine and oxaliplatin combination chemotherapy for metastatic well-differentiated neuroendocrine carcinomas: a single-center experiencePhilippe A Cassier, Thomas Walter, Beatrice Eymard, et al.
In Vivo (Athens, Greece)|October 19, 2010
Thrombogenicity of sirolimus-eluting stents and bare metal stents: evaluation in the early phase after stent implantationThomas Walter, Katja S Rey, Hans Peter Wendel, et al.
Neuroendocrinology|May 10, 2019
Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine TumorLouis de Mestier, Thomas Walter, Camille Evrard, et al.
Pageof 34